Accession Number:

ADA470865

Title:

The Role of Ubiquitin E3 Ligase SCF-SKP2 in Prostate Cancer Development

Descriptive Note:

Final rept. 19 Jan 2004-18 Jan 2007

Corporate Author:

YALE UNIV NEW HAVEN CT SCHOOL OF MEDICINE

Personal Author(s):

Report Date:

2007-02-01

Pagination or Media Count:

41.0

Abstract:

Low or absent expression of CDK inhibitor p27Kip1 is associated with malignant prostatecarcinomas. Loss of tumor suppressors p53 and Pten is also associated with prostate cancers. We found that p27 is regulated by both SCF-SKP2 and a novel ubiquitin E3 ligase containing CUL4-DDB1-WD40-repeat proteins. In addition, we have identified that a specific CUL4A-DDB1-L2DTLCDT2-PCNA ubiquitin E3 ligase binds and targets p53 polyubiquitination- dependentproteolysis in cooperation with MDM2. By interacting with a WD40-repeat proteins as asubstrate targeting subunit, the CUL4-DDB1 ubiquitin E3 ligase regulates a wide array of biological events including cell cycle regulation, genome stability, and histone methylationalteration of these events have been shown to associate with the development of prostatecarcinogenesis. We in addition found that expression of SKP2 and Pten heterozygosity do notcooperate in the mouse prostate carcinoma models, suggesting that SKP2 may act downstream ofPten pathway. Our work provides novel insights into the mechanism of prostate tumorigenesis.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE